Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations

v3.22.1
Discontinued Operations
3 Months Ended
Mar. 31, 2022
Discontinued Operations  
Discontinued Operations

7.    Discontinued Operations

​

The following table presents information related to assets and liabilities reported as discontinued operations in our condensed balance sheet:

​

​

​

​

​

​

​

​

​

​

March 31, 

    

December 31,

​

    

2022

    

2021

(In thousands)

​

​

  

 

​

  

Prepaid expenses and other current assets

​

$

24

​

$

12

Discontinued operations – current assets

​

$

24

​

$

12

​

​

​

​

​

​

​

Accounts payable

​

$

758

​

$

782

Accrued clinical trials expenses

​

 

6

​

 

—

Other accrued liabilities

​

 

362

​

 

362

Discontinued operations – current liabilities

​

$

1,126

​

$

1,144

​